Inactive

This amendment extends the due date and time for receipt of offers. See document for details.

Inactive

Continuation of SF-1449, Block 3: The following information shall be entered by the Contracting Officer at the time of contract award according to the timeframes specified in this solicitation s Secti... Continuation of SF-1449, Block 3: The following information shall be entered by the Contracting Officer at the time of contract award according to the timeframes specified in this solicitation s Section B, Scope of Contract, Section 1.4 Contract Effective Date, Implementation Period, and Ordering Period. Contract Award/Effective Date: ___________________ Implementation Period: __________________________ Ordering Period (Base Year): _____________________ Offerors shall not enter information into the above fields. Continuation of SF-1449, Blocks 19 through 24: To be considered for award, offerors must submit a price for line items 1 and 2 for the base year and all four option years. One award will be made in the aggregate for line items 1 and 2 for the base year and all four option years. Offered prices shall not exceed two decimal places. Note: NDC is defined as National Drug Code. ANDA is defined as Abbreviated New Drug Application Line Item 1 Acyclovir 200MG Capsules, 100 Capsules per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 3,256 Bottles Option Year One 3,256 Bottles Option Year Two 3,256 Bottles Option Year Three 3,256 Bottles Option Year Four 3,256 Bottles Line Item 2 Acyclovir 200MG Capsules, 500 Capsules per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 15,475 Bottles Option Year One 15,475 Bottles Option Year Two 15,475 Bottles Option Year Three 15,475 Bottles Option Year Four 15,475 Bottles